Informations sur le produit
NSC156529 is a drug candidate that inhibits the enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH). GAPDH is an essential enzyme in the glycolytic pathway that converts glucose to pyruvate. NSC156529 has been shown to inhibit platelet activation and regulate platelet function in vitro. This compound targets human cancer cells by inhibiting their aerobic glycolysis and inducing apoptosis, which leads to tumor cell death. NSC156529 also has the ability to interact with tumor xenografts and cancer cells in vivo, leading to tumor regression. NSC156529 was effective at inhibiting the growth of cancer cells in a mouse leukemia model with little effect on normal blood platelets.
Propriétés chimiques
Question d’ordre technique sur : 3D-RBA13488 NSC156529
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
